Herbas VPB

Print
EN | LT
LT - INHIBITING ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN (ATR)
EN - INHIBITING ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN (ATR)

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 9/1271 (2013.01)
A61K 48/00 (2006.01)
A61K 31/4745 (2006.01)
A61K 31/4745 (2013.01)
A61K 31/7068 (2006.01)
A61K 31/496 (2013.01)
A61K 31/555 (2006.01)
A61K 31/4965 (2013.01)
A61K 9/127 (2006.01)
A61K 31/497 (2013.01)
A61K 31/496 (2006.01)
A61K 31/555 (2013.01)
A61K 31/4965 (2006.01)
A61K 31/7068 (2013.01)
A61K 31/497 (2006.01)
A61P 35/00 (2018.01)
C07D 403/12 (2013.01)
C07D 403/12 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 3936153
(13) Kind of document T
(96) European patent application number 21182826.4
Date of filing the European patent application 2017-01-11
(97) Date of publication of the European application 2022-01-12
(45) Date of publication and mention of the grant of the patent 2024-08-21
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
201662277262 P 2016-01-11 US
201662420258 P 2016-11-10 US
201762444172 P 2017-01-09 US
Inventors
(72)
DRUMMOND, Daryl C. , US
GENG, Bolin , US
KIRPOTIN, Dmitri B. , US
TIPPARAJU, Suresh K. , US
KOSHKARYEV, Alexander , US
ALKAN, Ozan , US
Grantee
(73) Celator Pharmaceuticals, Inc. , 3170 Porter Drive, Palo Alto, CA 94304, US
Title
(54) INHIBITING ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN (ATR)
  INHIBITING ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN (ATR)